Korean Nationwide Surveillance of Antimicrobial Resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli

被引:11
作者
Lee, K
Kim, MY
Kang, SH
Kang, JO
Kim, EC
Choi, TY
Chong, Y
机构
[1] Yonsei Univ, Coll Med, Dept Lab Med, Seoul 120752, South Korea
[2] Dongguk Univ Coll Med, Pohang, South Korea
[3] Hallym Univ, Coll Med, Chunchon, South Korea
[4] Hanyang Univ, Coll Med, Kuri, South Korea
[5] Seoul Natl Univ, Coll Med, Seoul, South Korea
[6] Hanyang Univ, Coll Med, Seoul 133791, South Korea
关键词
antimicrobial resistance; Korean resistance surveillance; pathogenic bacteria;
D O I
10.3349/ymj.2003.44.4.571
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Antimicrobial resistance surveillance is necessary to determine the size of the problem and to guide empirical selection of antimicrobial agents for treating infected patients. The aim of this study was to analyze the results of susceptibility tests performed by hospitals participating in the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) program. The rates of oxacillin-resistant staphylococci, penicillin-non-susceptible pneumococci, and ampicillin-resistant E. faecium were over 70%. Ampicillin-resistant H. influenzae increased to 68%. Expanded-spectrum cephalosporin-resistant K. pneumoniae, fluoroquinolone-resistant E. coli, and imipenem-resistant P. aeruginosa remained at 16% through 27%, depending on the species. The proportions of vancomycin-resistant E. faecium and imipenem-resistant P. aeruginosa were 18-24% and 19-21%, respectively, indicating the seriousness of antimicrobial resistance. In conclusion, the increasing prevalence of resistant bacteria indicates that more concerted effort is required to conserve the usefulness of precious new antimicrobial agents.
引用
收藏
页码:571 / 578
页数:8
相关论文
共 33 条
[1]
Community-acquired pneumonia in adults: Guidelines for management [J].
Bartlett, JG ;
Breiman, RF ;
Mandell, LA ;
File, TM .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :811-838
[2]
Plasmid-encoded AmpC β-lactamases:: How far have we gone 10 years after the discovery? [J].
Bauernfeind, A ;
Chong, Y ;
Lee, K .
YONSEI MEDICAL JOURNAL, 1998, 39 (06) :520-525
[3]
Surveillance of antimicrobial resistance - what, how and whither? [J].
Bax, R ;
Bywater, R ;
Cornaglia, G ;
Goossens, H ;
Hunter, P ;
Isham, V ;
Jarlier, V ;
Jones, R ;
Phillips, I ;
Sahm, D ;
Senn, S ;
Struelens, M ;
Taylor, D ;
White, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (06) :316-325
[4]
Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications [J].
Chambers, HF .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :781-+
[5]
CAPSULAR TYPES AND ANTIMICROBIAL RESISTANCE OF STREPTOCOCCUS-PNEUMONIAE ISOLATED IN KOREA [J].
CHONG, Y ;
LEE, K ;
KWON, OH ;
HENRICHSEN, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (06) :528-531
[6]
Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997 [J].
Chong, Y ;
Lee, K ;
Park, YJ ;
Jeon, DS ;
Lee, MH ;
Kim, MY ;
Chang, CH ;
Kim, EC ;
Lee, NY ;
Kim, HS ;
Kang, ES ;
Cho, HC ;
Paik, IK ;
Lee, HS ;
Jang, SJ ;
Park, AJ ;
Cha, YJ ;
Kang, SH ;
Lee, MH ;
Song, W ;
Shin, JH .
YONSEI MEDICAL JOURNAL, 1998, 39 (06) :569-577
[7]
[8]
THE CAUSATIVE ORGANISMS OF SEPTICEMIA AND THEIR EPIDEMIOLOGY [J].
EYKYN, SJ ;
GRANSDEN, WR ;
PHILLIPS, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :41-58
[9]
Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals [J].
Fridkin, SK ;
Hill, HA ;
Volkova, NV ;
Edwards, JR ;
Lawton, RM ;
Gaynes, RP ;
McGowan, JE .
EMERGING INFECTIOUS DISEASES, 2002, 8 (07) :697-701
[10]
Dissemination of vancomycin-resistant enterococci harboring vanA through disposal of waste derived from industrial production of vancomycin [J].
Guardabassi, L ;
Bronnum, PT ;
Dano, R ;
Forslund, A ;
Dalsgaard, A .
MICROBIAL DRUG RESISTANCE, 2002, 8 (04) :401-406